CareLit · DOI-Nachweis · Pneumologie
Efficacy and safety of selexipag in pulmonary arterial hypertension (PAH) patients with and without significant cardiovascular (CV) comorbidities
DOI 10.1055/s-0039-3403192
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Rosenkranz, R Channick, K Chin, B Jenner, S Gaine, N Galie, HA Ghofrani, MM Hoeper, V McLaughlin, R Preiss, L Rubin, G Simonneau, O Sitbon, V Tapson, I Lang
ZeitschriftPneumologie
AusgabeS 01 S 01/2020
Jahrgang / SeitenJg. 74
Kernaussage aus der Literatur
Abstract-Vorschau
Efficacy and safety of selexipag in pulmonary arterial hypertension (PAH) patients with and without significant cardiovascular (CV) comorbidities
Zitieren
Zitierempfehlung
S Rosenkranz, R Channick, K Chin, B Jenner, S Gaine, N Galie, HA Ghofrani, MM Hoeper, V McLaughlin, R Preiss, L Rubin, G Simonneau, O Sitbon, V Tapson, I Lang (2020) Efficacy and safety of selexipag in pulmonary arterial hypertension (PAH) patients with and without significant cardiovascular (CV) comorbidities. Pneumologie, 74 (S 01 S 01). https://doi.org/10.1055/s-0039-3403192
Mit CareLit weiterarbeiten